Human serum albumin: News about an old acquaintance;Humant serumalbumin: Nyt om en gammel bekendt

Ugeskrift for Laeger

Volumn 169, Issue 41, 2007, Pages 3467-3470

  Kragh Hansen, Ulrich ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; LIGAND; PRODRUG; SERUM ALBUMIN;

CHEMISTRY; CRYSTALLOGRAPHY; ENZYME ACTIVATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANTIOXIDANTS; CRYSTALLOGRAPHY; ENZYME ACTIVATION; HUMANS; LIGANDS; PRODRUGS; SERUM ALBUMIN;

EID: 35848963386     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Peters T Jr. All about albumin: biochemistry, genetics, and medical applications. San Diego: Academic Press, 1996.
2. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981;33:17-53.
3. Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994;45:153-203.
4. Kragh-Hansen U, Chuang VTG, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002;25:695-704.
5. 2+ binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001;268:42-7.
6. Stewart AJ, Blindauer CA, Berezenko S et al. Interdomain zinc site on human albumin. Proc Natl Acad Sci USA 2003;100:3701-6.
7. Kragh-Hansen U, Vorum H. Quantitative analyses of the interaction between calcium ions and human serum albumin. Clin Chem 1993;39:202-8.
8. Bhagavan NV, Lai EM, Rios PA et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5.
9. Ferrer ML, Duchowicz R, Carrasco B et al. The conformation of serum albumin in solution: a combined phosphorescence depolarization-hydrodynamic modelling study. Biophys J 2001;80:2422-30.
10. Bhattacharya AA, Grüne T, Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 2000;303:721-32.
11. Petitpas I, Grüne T, Bhattacharya AA et al. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol 2001;314:955-60.
12. Kragh-Hansen U, Watanabe H, Nakajou K et al. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. J Mol Biol 2006;363:702-12.
13. Zunszain P, Ghuman J, Komatsu T et al. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct Biol 2003;3:artikel 6.
14. Petitpas I, Petersen CE, Ha C-E et al. Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc Natl Acad Sci USA 2003;100:6440-5.
15. Lejon S, Frick I-M, Björck L et al. Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J Biol Chem 2004;279:42924-8.
16. Ghuman J, Zunszain PA, Petitpas I et al. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 2005;353:38-52.
17. Petitpas I, Bhattacharya AA, Twine S et al. Crystal structure analysis of warfarin binding to human serum albumin. Anatomy of drug site I. J Biol Chem 2001;276:22804-9.
18. Bhattacharya AA, Curry S, Franks NP. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem 2000;275:38731-8.
19. Soran H, Younis N. Insulin detemir: a new basal insulin analogue. Diabetes Obes Metab 2006;8:26-30.
20. Mitzner S, Klammt S, Stange J et al. Albumin regeneration in liver support - comparison of different methods. Ther Apher Dial 2006;10:108-17.
21. Millot MC. Separation of drug enantiomers by liquid chromatography and capillary electrophoresis, using immobilized proteins as chiral selectors. J Chromatogr B 2003;797:131-59.
22. Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001;3:293-311.
23. Halliwell B. Albumin - an important extracellular antioxidant. Biochem Pharmacol 1988;37:569-71.
24. Anraku M, Yamasaki K, Maruyama T et al. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res 2001;18:632-9.
25. Watanabe T, Narumiya S, Shimizu T et al. Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma. J Biol Chem 1982;257:14847-53.
26. Fitzpatrick FA, Wynalda MA. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem 1983;258:11713-8.
27. Yang J, Petersen CE, Ha C-E et al. Structural insights into human serum albumin-mediated prostaglandin catalysis. Protein Sci 2002;11:538-45.
28. Drmanovic Z, Voyatzi S, Kouretas D et al. Albumin possesses intrinsic enolase activity towards dihydrotestosterone which can differentiate benign from malignant breast tumors. Anticancer Res 1999;19:4113-24.
29. Agarwal RP, Phillips M, McPherson RA et al. Serum albumin and the metabolism of disulfiram. Biochem Pharmacol 1986;35:3341-7.
30. Watanabe H, Tanase S, Nakajou K et al. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J 2000;349:813-9.
31. Sakurai Y, Ma S-F, Watanabe H et al. Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm Res 2004;21:285-92.
32. Ma S-F, Anraku M, Iwao Y et al. Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug Metab Dispos 2005;33:1911-9.